0
6. 6. 2026.
Corrigendum to “Long-term real-world survival outcomes with dual immune checkpoint blockade in synchronous metastatic renal cell carcinoma: implications for the design of prospective cytoreductive nephrectomy trials” [Eur. Urol. Open Sci. 83 (2026) 133–141]
[This corrects the article DOI: 10.1016/j.euros.2025.12.004.].